If a variant has more than two submissions, it may have multiple conflicts and therefore be counted in more than one conflict column. If this is the case, the "Variants with any kind of conflict" cell will be less than the sum of the conflicted variants cells to its left.
| Variants with only 1 submission per condition | Variants with at least 2 submissions on the same condition and no conflicts |
Variants with a synonymous conflict (e.g. benign vs non-pathogenic) |
Variants with a confidence conflict (e.g. benign vs likely benign) |
Variants with a benign or likely benign vs uncertain conflict |
Variants with a category conflict (e.g. benign vs affects) |
Variants with a clinically significant conflict (e.g. benign vs pathogenic) |
Variants with any conflict |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 40 | 0 | 40 |
Significance breakdown #
In the table below, cells that correspond to a term paired with itself represent synonymous conflicts, i.e. variants that have been annotated with different terms that map to the same standard term. To compare the terms that were actually submitted, check the box in the filters section at the top of this page.
| All conditions | |||||
|---|---|---|---|---|---|
| halothane response - Toxicity | pathogenic | likely pathogenic | uncertain significance | risk factor | |
| drug response | 38 | 19 | 7 | 12 | |
Condition to condition summary #
Total conditions: 8
| Condition | Variants with only 1 submission per condition | Variants with at least 2 submissions on the same condition and no conflicts |
Variants with a synonymous conflict (e.g. benign vs non-pathogenic) |
Variants with a confidence conflict (e.g. benign vs likely benign) |
Variants with a benign or likely benign vs uncertain conflict |
Variants with a category conflict (e.g. benign vs affects) |
Variants with a clinically significant conflict (e.g. benign vs pathogenic) |
Variants with any conflict |
|---|---|---|---|---|---|---|---|---|
| Malignant hyperthermia, susceptibility to, 1 | 0 | 0 | 0 | 0 | 0 | 38 | 0 | 38 |
| RYR1-related disorder | 0 | 0 | 0 | 0 | 0 | 32 | 0 | 32 |
| not provided | 0 | 9 | 0 | 0 | 0 | 31 | 0 | 31 |
| Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 4 |
| Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 2 |
| Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 2 |
| Malignant hyperthermia, susceptibility to, 5 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 2 |
| not specified | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
All variants with conflicting interpretations #
Total variants: 40